Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Total Debt (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Total Debt for 11 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Debt fell 27.19% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 27.19% decrease, with the full-year FY2025 number at $2.8 million, down 27.19% from a year prior.
  • Total Debt was $2.8 million for Q4 2025 at Ekso Bionics Holdings, down from $3.0 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $5.1 million in Q3 2023 to a low of $2.0 million in Q2 2021.
  • A 5-year average of $3.3 million and a median of $3.3 million in 2025 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: crashed 35.3% in 2021, then skyrocketed 89.01% in 2022.
  • Ekso Bionics Holdings' Total Debt stood at $2.0 million in 2021, then surged by 89.01% to $3.8 million in 2022, then grew by 28.27% to $4.8 million in 2023, then decreased by 20.24% to $3.9 million in 2024, then fell by 27.19% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Total Debt are $2.8 million (Q4 2025), $3.0 million (Q3 2025), and $3.3 million (Q2 2025).